Clinical Trials · NCT05716724
O-SEMA-Fast: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Plan to Fast During Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 288
- Start date
- Jan 2023
- Locations
- 20 sites, 3 countries
- Primary endpoint
- Change in glycated haemoglobin (HbA1c)